125 related articles for article (PubMed ID: 37285280)
1. Bioinformatics Analysis Reveals the Vital Role of AKR1B1 in Immune Infiltration and Clinical Outcomes of Gastric Cancer.
Zhao Z; Hao Z; Zhang Z; Zhan X
DNA Cell Biol; 2023 Jul; 42(7):372-389. PubMed ID: 37285280
[TBL] [Abstract][Full Text] [Related]
2. ZNF521/EBF1 axis regulates AKR1B1 to promote the proliferation, migration, and invasion of gastric cancer cells.
Cheng Y; Ni YJ; Tang LM
Kaohsiung J Med Sci; 2023 Mar; 39(3):244-253. PubMed ID: 36397644
[TBL] [Abstract][Full Text] [Related]
3. The Expression and Clinical Significance of Aldo-Keto Reductase 1 Member B1 in Gastric Carcinoma.
Li X; Yang J; Gu X; Xu J; Li H; Qian J; Chen L
DNA Cell Biol; 2020 Jul; 39(7):1322-1327. PubMed ID: 32412859
[TBL] [Abstract][Full Text] [Related]
4. Expression of AKRs superfamily and prognostic in human gastric cancer.
Zhou Y; Lin Y; Li W; Liu Q; Gong H; Li Y; Luo D
Medicine (Baltimore); 2023 Feb; 102(8):e33041. PubMed ID: 36827074
[TBL] [Abstract][Full Text] [Related]
5. Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer.
Taskoparan B; Seza EG; Demirkol S; Tuncer S; Stefek M; Gure AO; Banerjee S
Cell Oncol (Dordr); 2017 Dec; 40(6):563-578. PubMed ID: 28929377
[TBL] [Abstract][Full Text] [Related]
6. A Potential Prognostic Biomarker for Glioma: Aldo-Keto Reductase Family 1 Member B1.
Zhao H; Dong X; Huang T; Li X
Comput Intell Neurosci; 2022; 2022():9979200. PubMed ID: 35341178
[TBL] [Abstract][Full Text] [Related]
7. Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature.
Zhang S; Lv M; Cheng Y; Wang S; Li C; Qu X
BMC Cancer; 2021 Dec; 21(1):1324. PubMed ID: 34893046
[TBL] [Abstract][Full Text] [Related]
8. Gastric Cancer Immune Subtypes and Prognostic Modeling: Insights from Aging-Related Gene Analysis.
Shen J; Li M
Crit Rev Immunol; 2024; 44(5):1-13. PubMed ID: 38618724
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics analysis of the prognosis and biological significance of VCAN in gastric cancer.
Huang XY; Liu JJ; Liu X; Wang YH; Xiang W
Immun Inflamm Dis; 2021 Jun; 9(2):547-559. PubMed ID: 33631054
[TBL] [Abstract][Full Text] [Related]
10. Role of aldo-keto reductase family 1 member B1 (AKR1B1) in the cancer process and its therapeutic potential.
Khayami R; Hashemi SR; Kerachian MA
J Cell Mol Med; 2020 Aug; 24(16):8890-8902. PubMed ID: 32633024
[TBL] [Abstract][Full Text] [Related]
11. Ī²2-AR regulates the expression of AKR1B1 in human pancreatic cancer cells and promotes their proliferation via the ERK1/2 pathway.
Xiao MB; Jin DD; Jiao YJ; Ni WK; Liu JX; Qu LS; Lu CH; Ni RZ; Jiang F; Chen WC
Mol Biol Rep; 2018 Dec; 45(6):1863-1871. PubMed ID: 30306507
[TBL] [Abstract][Full Text] [Related]
12. ALDOC regulated the biological function and immune infiltration of gastric cancer cells.
Chen L; Zeng Y; Ren B; Wang X; Zhao F; Du J; Zhang R; Deng J
Int J Biochem Cell Biol; 2023 May; 158():106407. PubMed ID: 36997056
[TBL] [Abstract][Full Text] [Related]
13. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
[No Abstract] [Full Text] [Related]
14. LncRNA HOTAIR promotes the growth and metastasis of gastric cancer by sponging miR-1277-5p and upregulating COL5A1.
Wei Z; Chen L; Meng L; Han W; Huang L; Xu A
Gastric Cancer; 2020 Nov; 23(6):1018-1032. PubMed ID: 32583079
[TBL] [Abstract][Full Text] [Related]
15. Aldo-keto reductase family 1 member B1 inhibitors: old drugs with new perspectives.
Liu J; Wen G; Cao D
Recent Pat Anticancer Drug Discov; 2009 Nov; 4(3):246-53. PubMed ID: 19522700
[TBL] [Abstract][Full Text] [Related]
16. The AKR1B1 inhibitor epalrestat suppresses the progressionĀ of cervical cancer.
Ji J; Xu MX; Qian TY; Zhu SZ; Jiang F; Liu ZX; Xu WS; Zhou J; Xiao MB
Mol Biol Rep; 2020 Aug; 47(8):6091-6103. PubMed ID: 32761301
[TBL] [Abstract][Full Text] [Related]
17. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
Front Immunol; 2021; 12():651033. PubMed ID: 34054812
[TBL] [Abstract][Full Text] [Related]
18. Development and verification of an immune-related gene prognostic index for gastric cancer.
Zhang C; Liu T; Wang J; Zhang J
Sci Rep; 2022 Sep; 12(1):15693. PubMed ID: 36127384
[TBL] [Abstract][Full Text] [Related]
19. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma.
Khan M; Lin J; Wang B; Chen C; Huang Z; Tian Y; Yuan Y; Bu J
Front Immunol; 2022; 13():968165. PubMed ID: 36389725
[TBL] [Abstract][Full Text] [Related]
20. Identification of pivotal genes associated with the prognosis of gastric carcinoma through integrated analysis.
Ma Z; Xu J; Ru L; Zhu W
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33754626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]